ResearcherShanghai Jiao Tong UniversityNo recent work listed
Weifeng Song
Matched on OpenAlex author ID A5101202102. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: none · 2015: 3 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers
Papers 7
- FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling. Co-author DOI 10.1186/s13046-019-1174-3↗
- MiR-27a-regulated FOXO1 promotes pancreatic ductal adenocarcinoma cell progression by enhancing Wnt/β-catenin signaling activity. Co-author PMID 31217876↗
- EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic ca… Co-author DOI 10.18632/oncotarget.7156↗
- Interplay of miR-21 and FoxO1 modulates growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3123-x↗
- FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/srep10081↗
- Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma. Co-author DOI 10.1159/000369686↗
- MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer… Co-author DOI 10.7314/apjcp.2013.14.12.7529↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Liwei Wang · 4 shared papers, 2013–2016 · strength 0.24
- Paper Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma. DOI 10.1159/000369686↗
- Paper FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma. DOI 10.1038/srep10081↗
- Paper EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through a… DOI 10.18632/oncotarget.7156↗
- Ling Jing · 2 shared papers, 2019 · strength 0.21
- Qi Li · 2 shared papers, 2019 · strength 0.21
- Xuebing Jia · 2 shared papers, 2019 · strength 0.21
- Lei Wang · 2 shared papers, 2015 · strength 0.14
- Weiyi Huang · 2 shared papers, 2013–2015 · strength 0.11
- Lei Wang · 1 shared paper, 2019 · strength 0.11
- Qi Li · 1 shared paper, 2015 · strength 0.07
- Liwei Wang · 1 shared paper, 2015 · strength 0.07
- Ting Han · 1 shared paper, 2016 · strength 0.06
- Feng Jiao · 1 shared paper, 2016 · strength 0.06
- Hai Xia Hu · 1 shared paper, 2016 · strength 0.06
- Lei Wang · 1 shared paper, 2013 · strength 0.04
- Jiujie Cui · 1 shared paper, 2013 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.